Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care

Abstract Wiskott Aldrich syndrome (WAS) is a rare disease and hematopoietic stem cell transplant (HCT) is considered the treatment modality of choice for WAS. We conducted a cross-sectional analysis on the KIDS’ pediatric inpatient database and compared hospitalization rates, complications and healt...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nikki Agarwal, Divyaswathi Citla Sridhar, Sindhoosha Malay, Nirav Patil, Anjali Shekar, Sanjay Ahuja, Jignesh Dalal
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/03219b2c17e24e6dbef06473680f994d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:03219b2c17e24e6dbef06473680f994d
record_format dspace
spelling oai:doaj.org-article:03219b2c17e24e6dbef06473680f994d2021-12-02T15:53:44ZWiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care10.1038/s41598-021-84328-02045-2322https://doaj.org/article/03219b2c17e24e6dbef06473680f994d2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84328-0https://doaj.org/toc/2045-2322Abstract Wiskott Aldrich syndrome (WAS) is a rare disease and hematopoietic stem cell transplant (HCT) is considered the treatment modality of choice for WAS. We conducted a cross-sectional analysis on the KIDS’ pediatric inpatient database and compared hospitalization rates, complications and healthcare utilizations in the transplant and non-transplant arms. Of the 383 pediatric admissions with diagnosis of WAS between 2006–2012, 114 underwent transplant and 269 did not. The non-transplant arm included older children, female patients and more African Americans. Death rates, income and payer source were similar in both arms, however the total charge for each admission was higher in the transplant arm. Emergency room visits were similar but non-elective admissions were more in the non-transplant arm. Length of stay was prolonged in the transplant arm. When comparing morbidities, lymphomas, ulcerative colitis and autoimmune complications of WAS were seen only in the non-transplant arm. Our study shows that transplant is the largest contributor to healthcare utilization in WAS patients. We identified healthcare disparities based on race and socioeconomic status and found that this rare disease is being appropriately directed to centers with HCT expertise. We noted a change in practice moving away from splenectomy in WAS patients.Nikki AgarwalDivyaswathi Citla SridharSindhoosha MalayNirav PatilAnjali ShekarSanjay AhujaJignesh DalalNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Nikki Agarwal
Divyaswathi Citla Sridhar
Sindhoosha Malay
Nirav Patil
Anjali Shekar
Sanjay Ahuja
Jignesh Dalal
Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care
description Abstract Wiskott Aldrich syndrome (WAS) is a rare disease and hematopoietic stem cell transplant (HCT) is considered the treatment modality of choice for WAS. We conducted a cross-sectional analysis on the KIDS’ pediatric inpatient database and compared hospitalization rates, complications and healthcare utilizations in the transplant and non-transplant arms. Of the 383 pediatric admissions with diagnosis of WAS between 2006–2012, 114 underwent transplant and 269 did not. The non-transplant arm included older children, female patients and more African Americans. Death rates, income and payer source were similar in both arms, however the total charge for each admission was higher in the transplant arm. Emergency room visits were similar but non-elective admissions were more in the non-transplant arm. Length of stay was prolonged in the transplant arm. When comparing morbidities, lymphomas, ulcerative colitis and autoimmune complications of WAS were seen only in the non-transplant arm. Our study shows that transplant is the largest contributor to healthcare utilization in WAS patients. We identified healthcare disparities based on race and socioeconomic status and found that this rare disease is being appropriately directed to centers with HCT expertise. We noted a change in practice moving away from splenectomy in WAS patients.
format article
author Nikki Agarwal
Divyaswathi Citla Sridhar
Sindhoosha Malay
Nirav Patil
Anjali Shekar
Sanjay Ahuja
Jignesh Dalal
author_facet Nikki Agarwal
Divyaswathi Citla Sridhar
Sindhoosha Malay
Nirav Patil
Anjali Shekar
Sanjay Ahuja
Jignesh Dalal
author_sort Nikki Agarwal
title Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care
title_short Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care
title_full Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care
title_fullStr Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care
title_full_unstemmed Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care
title_sort wiskott aldrich syndrome: healthcare utilizations and disparities in transplant care
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/03219b2c17e24e6dbef06473680f994d
work_keys_str_mv AT nikkiagarwal wiskottaldrichsyndromehealthcareutilizationsanddisparitiesintransplantcare
AT divyaswathicitlasridhar wiskottaldrichsyndromehealthcareutilizationsanddisparitiesintransplantcare
AT sindhooshamalay wiskottaldrichsyndromehealthcareutilizationsanddisparitiesintransplantcare
AT niravpatil wiskottaldrichsyndromehealthcareutilizationsanddisparitiesintransplantcare
AT anjalishekar wiskottaldrichsyndromehealthcareutilizationsanddisparitiesintransplantcare
AT sanjayahuja wiskottaldrichsyndromehealthcareutilizationsanddisparitiesintransplantcare
AT jigneshdalal wiskottaldrichsyndromehealthcareutilizationsanddisparitiesintransplantcare
_version_ 1718385490736971776